Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-74,100
Closed -$5.68M 55
2024
Q4
$5.68M Hold
74,100
0.15% 68
2024
Q3
$6.19M Hold
74,100
0.21% 59
2024
Q2
$4.09M Hold
74,100
0.14% 54
2024
Q1
$5.15M Buy
+74,100
New +$4.7M 0.12% 60

Other funds holding ACLX

Duquesne Family Office's ACLX Position: Q1 2025 in Review

Duquesne Family Office sold out of Arcellx (ACLX) in Q1 2025, closing a stake of 74,100 shares — an estimated $5.68M sold.

Duquesne Family Office first reported a position in ACLX in Q1 2024 and held it in 4 quarters. The position peaked at $6.19M in Q3 2024. 197 funds tracked by Wall St. Rank hold ACLX as of Q1 2025.

  • Duquesne Family Office reported no remaining Arcellx position as of Q1 2025 after selling out during the quarter.
  • Duquesne Family Office sold 74,100 Arcellx shares in Q1 2025, an estimated $5.68M.
  • Duquesne Family Office first reported a position in Arcellx in Q1 2024 and held it in 4 quarters.
  • Duquesne Family Office's Arcellx position peaked at $6.19M in Q3 2024.
  • 197 funds tracked by Wall St. Rank held Arcellx as of Q1 2025.

Based on Duquesne Family Office's 13F filing for Q1 2025, filed 15 May 2025.